{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T09:58:43Z","timestamp":1792403923669,"version":"4.4.0"},"reference-count":17,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["brachyjournal.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Brachytherapy"],"published-print":{"date-parts":[[2022,11]]},"DOI":"10.1016\/j.brachy.2022.08.006","type":"journal-article","created":{"date-parts":[[2022,9,19]],"date-time":"2022-09-19T08:27:18Z","timestamp":1663576038000},"page":"896-903","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Clinical characteristics and postoperative complications as predictors of radiation toxicity after treatment with I125 Eye Plaque Brachytherapy for Uveal Melanomas"],"prefix":"10.1016","volume":"21","author":[{"given":"Vanessa","family":"Peters","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5876-9651","authenticated-orcid":false,"given":"Aaron","family":"Gurayah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9644-3364","authenticated-orcid":false,"given":"William","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deukwoo","family":"Kwon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7336-0459","authenticated-orcid":false,"given":"Wei","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nirav V.","family":"Patel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arnold","family":"Markoe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zelia","family":"Correa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7415-7225","authenticated-orcid":false,"given":"Matthew T.","family":"Studenski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. William","family":"Harbour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stuart E.","family":"Samuels","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.brachy.2022.08.006_bib0001","series-title":"Clinical opthalmic oncology","first-page":"53","article-title":"Uveal Melanoma: epidemiologic Aspects","author":"Singh","year":"2019"},{"key":"10.1016\/j.brachy.2022.08.006_bib0002","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1038\/eye.2016.275","article-title":"Uveal melanoma: relatively rare but deadly cancer","volume":"31","author":"Kaliki","year":"2017","journal-title":"Eye"},{"key":"10.1016\/j.brachy.2022.08.006_bib0003","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1016\/j.ophtha.2014.08.046","article-title":"Management of posterior uveal melanoma: past, present, and future: the 2014 Charles L. Schepens lecture","volume":"122","author":"Shields","year":"2015","journal-title":"Ophthalmology"},{"key":"10.1016\/j.brachy.2022.08.006_bib0004","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1177\/1740774511419684","article-title":"Collaborative ocular melanoma study randomized trial of I-125 brachytherapy","volume":"8","author":"Hawkins","year":"2011","journal-title":"Clin Trials"},{"key":"10.1016\/j.brachy.2022.08.006_bib0005","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1038\/eye.2009.43","article-title":"Ocular complications following I-125 brachytherapy for choroidal melanoma","volume":"23","author":"Wen","year":"2009","journal-title":"Eye"},{"key":"10.1016\/j.brachy.2022.08.006_bib0006","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1038\/eye.1991.39","article-title":"Radiation retinopathy\u2013clinical, histopathological, ultrastructural and experimental correlations","volume":"5","author":"Archer","year":"1991","journal-title":"Eye (Lond)"},{"key":"10.1016\/j.brachy.2022.08.006_bib0007","doi-asserted-by":"crossref","first-page":"392","DOI":"10.5114\/jcb.2019.87407","article-title":"Complications and adverse events of plaque brachytherapy for ocular melanoma","volume":"11","author":"Peddada","year":"2019","journal-title":"J Contemp Brachytherapy"},{"key":"10.1016\/j.brachy.2022.08.006_bib0008","doi-asserted-by":"crossref","first-page":"1768","DOI":"10.1016\/j.ophtha.2004.03.027","article-title":"Ocular complications after iodine brachytherapy for large uveal melanomas","volume":"111","author":"Puusaari","year":"2004","journal-title":"Ophthalmology"},{"key":"10.1016\/j.brachy.2022.08.006_bib0009","doi-asserted-by":"crossref","first-page":"540","DOI":"10.5114\/jcb.2017.71795","article-title":"Nomogram for predicting radiation maculopathy in patients treated with Ruthenium-106 plaque brachytherapy for uveal melanoma","volume":"9","author":"Tagliaferri","year":"2017","journal-title":"J Contemp Brachytherapy"},{"key":"10.1016\/j.brachy.2022.08.006_bib0010","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1118\/1.596585","article-title":"Optimization of 125I ophthalmic plaque brachytherapy","volume":"17","author":"Astrahan","year":"1990","journal-title":"Med Phys"},{"key":"10.1016\/j.brachy.2022.08.006_bib0011","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1097\/IAE.0b013e3182340cc1","article-title":"Vitreous hemorrhage after plaque radiotherapy for uveal melanoma","volume":"32","author":"Bianciotto","year":"2012","journal-title":"Retina"},{"key":"10.1016\/j.brachy.2022.08.006_bib0012","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1016\/j.survophthal.2017.05.001","article-title":"Exudative retinal detachment","volume":"62","author":"Amer","year":"2017","journal-title":"Surv Ophthalmol"},{"key":"10.1016\/j.brachy.2022.08.006_bib0013","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.ajo.2012.06.026","article-title":"Intravitreal triamcinolone versus intravitreal bevacizumab in the treatment of exudative retinal detachment secondary to posterior uveal melanoma","volume":"155","author":"Parrozzani","year":"2013","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.brachy.2022.08.006_bib0014","doi-asserted-by":"crossref","first-page":"796","DOI":"10.5301\/EJO.2011.6477","article-title":"Systemic bevacizumab (Avastin) for exudative retinal detachment secondary to choroidal melanoma","volume":"21","author":"Newman","year":"2011","journal-title":"Eur J Ophthalmol"},{"key":"10.1016\/j.brachy.2022.08.006_bib0015","doi-asserted-by":"crossref","first-page":"201","DOI":"10.3109\/02713683.2014.906625","article-title":"Gender differences in ocular blood flow","volume":"40","author":"Schmidl","year":"2015","journal-title":"Curr Eye Res"},{"key":"10.1016\/j.brachy.2022.08.006_bib0016","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/S0002-9394(02)02292-4","article-title":"Laser and proton radiation to reduce uveal melanoma\u2013associated exudative retinal detachments","volume":"136","author":"Char","year":"2003","journal-title":"Am J Ophthalmo"},{"key":"10.1016\/j.brachy.2022.08.006_bib0017","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.visres.2017.04.003","article-title":"The pathology associated with diabetic retinopathy","volume":"139","author":"Lechner","year":"2017","journal-title":"Vision Res"}],"container-title":["Brachytherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538472122001489?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538472122001489?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T02:18:01Z","timestamp":1761531481000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1538472122001489"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11]]},"references-count":17,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2022,11]]}},"alternative-id":["S1538472122001489"],"URL":"https:\/\/doi.org\/10.1016\/j.brachy.2022.08.006","relation":{},"ISSN":["1538-4721"],"issn-type":[{"value":"1538-4721","type":"print"}],"subject":[],"published":{"date-parts":[[2022,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Clinical characteristics and postoperative complications as predictors of radiation toxicity after treatment with I125 Eye Plaque Brachytherapy for Uveal Melanomas","name":"articletitle","label":"Article Title"},{"value":"Brachytherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.brachy.2022.08.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 American Brachytherapy Society. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}